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Objective: To determine if the intrapartum use 
of a 5% glucose-containing intravenous solution 
decreases the chance of a cesarean delivery for 
women presenting in active labor.
Methods: This was a multi-center, prospective, 
single (patient) blind, randomized study design 
implemented at 4 obstetric residency programs in 
Pennsylvania. Singleton, term, consenting women 
presenting in active spontaneous labor with a 
cervical dilation of <6cm were randomized to 
lactated Ringer’s with or without 5% glucose (LR 
versus D5LR) as their maintenance intravenous fluid. 
The primary outcome was the cesarean birth rate. 
Secondary outcomes included labor characteristics, 
as well as maternal or neonatal complications. Log-
binomial regression was used to assess risk ratios 
(RR) and 95% confidence intervals (CI) after adjusting 
for participating center.
Results: There were 309 women analyzed from 4 
hospital sites. Demographic variables and admitting 
cervical dilation were similar among study groups. 
There was no significant difference in the cesarean 
delivery rate for the D5LR group (23/153 or 15.0%) versus the 
LR arm (18/156 or 11.5%), [RR (95%CI) of 1.32 (0.75, 2.35), 
P=0.34]. There were no differences in augmentation rates or 
intrapartum complications. The postpartum hemorrhage rate 
was 6.0% in the LR arm and 1.3% in the D5LR arm, P=0.05). 
There also was a marginally higher rate of neonatal hypoglycemia 
(glucose < 40 mg/dL) and 5 minute Apgar scores <7 in the D5LR 
group versus the LR group.
Conclusions: The use of intravenous fluid containing 5% 
dextrose does not lower the chance of cesarean delivery for 
women admitted in active labor.
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Background: 
 •  Adequate caloric and fluid intake is 
important for muscle performance
 •  The uterus is a muscle undergoing 
work during labor
 •  Data suggest adding glucose to 
maintenance IV fluids in labor 
   –  May shorten labor duration in 
nulliparas
   –  May reduce umbilical artery 
acidemia and hypercarbia
Conclusions: 
 • Stratify patients into predetermined categories: 
   –  Vancomycin dosing and age range 
 •  Assess relationship between categories
 •  Evaluate attainment of vancomycin concentrations within each category 
 •  Patient-specific information to be collected will include:   
   –  Age [PMA and Postnatal age (PNA)] 
   –  Weight
   –  Vancomycin dose and frequency
   –  Days of vancomycin therapy
   –  Measured vancomycin trough concentrations
   –  Timing of vancomycin trough concentrations
   –  Location of infection and organism
   –  Documentation of organism eradication via cultures or clinical 
determination by the neonatologist
   –  Daily serum creatinine from drug initiation to discontinuation
   –  Presence of any co-administered nephrotoxic drugs  
Abstract: 
Note: Study halted by DSMC due to overall lower than expected cesarean rates 
and revised sample size calculation showing unattainable target of 3374 subjects.
Hypotheses: 
 •  IV hydration during labor with a 
glucose-containing fluid will lead to 
more efficient uterine contractility 
and will lead to a reduction of 
cesarean delivery and improved 
labor characteristics in women 
presenting in active labor.
 •  There is no increase in maternal or 
neonatal complications if glucose is 
used in IV fluids in labor
Materials and 
Methods: 
 •  Multi-center (4 regional OB/GYN 
residency programs)
 •  Prospective randomized single-blind
 •  Singleton in spontaneous labor with 
cervix <6cm dilation
 •  No glycemic dysregulation condition, 
steroids, prior cesarean, induction
 •  Randomized to maintenance IV fluid 
of either 
   –  Lactated Ringers (LR)
   –  Lactated ringers with 5% 
glucose (D5LR)
 •  Any needed bolus of IVF was LR
 •  Randomization stratified by site
 •  Analyses
   –  Risk Ratios (RR) and 95% CI
   –  Log-binomial regression 
models
   –  Parametric and non-parametric 
tests 
 •  Data Safety Monitoring Committee
Results: 
Primary Outcomes: 
 •  No difference in cesarean 
delivery rate
   –  D5LR-15% and LR-11.5%
   –  RR (95% CI) of 1.32 (0.75, 
2.35); P=0.34
 •  No difference in cesarean 
delivery rate after adjusting for 
ketonuria
   –  RR (95% CI) of 1.37 (0.78, 
2.41); P=0.34
 •  No difference in labor onset to 
delivery time     
   –  Cox proportional hazards 
(95% CI) of 1.00 (0.80, 
1.26); P=0.99
Conclusions:
 •  The addition of glucose to maintenance intrapartum IV fluids for women in spontaneous active labor at <6m: 
   –  Does not reduce the cesarean delivery rate
   –  Does not shorten labor
   –  Does not lower oxytocin augmentation rate
   –  Does not change complication rates except marginally more cases of neonatal hypoglycemia and 5 minute Apgar scores <7, 
and marginally fewer postpartum hemorrhages
Note: Data reported as mean ± SD [n] for continuous variables and proportion (%) for categorical 
variables, with the exception of admission dilation (cm) which is reported as median (25th, 75th 
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Figure 1.
Randomization Flowchart
Table 1: Demographic and labor characteristics compared   





Maternal age (years) 26.8 ± 4.9 [156] 26.7 ± 4.9 [153] 0.87 
Nulliparity 86/156 (55.1%) 83/151 (55.0%) 0.99
Hispanic 12/156 (7.7%) 21/152 (13.8%) 0.09
Race 0.19
     Caucasian 127/156 (81.4%) 129/151 (85.4%)
     African American 11/156 (7.1%) 4/151 (2.7%)
     Other 18/156 (11.5%) 18/151 (11.9%)
Private Insurance 116/153 (75.8%) 111/152 (73.0%) 0.57
> 12th Grade Education 93/136 (68.4%) 89/133 (66.9%) 0.84
Tobacco use 17/153 (11.1%) 15/152 (9.9%) 0.72
Alcohol use 4/153 (2.6%) 9/145 (6.2%) 0.13
Initial BMI (kg/m2) 26.5 ± 5.8 [148] 26.1 ± 6.5 [147] 0.63
Initial weight (kg) 69.8 ± 15.1 [152] 69.5 ± 17.5 [148] 0.87
Weight gain (kg) 12.0 ± 6.6 [150] 13.5 ± 9.9 [148] 0.14
Hypertensive disorders 2/156 (1.3%) 0/153 (0%) 0.17
Ketonuria on admission 15/106 (14.2%) 8/103 (7.8%) 0.23
Admission dilation (cm) 4.0 (3.0, 4.0) [156] 4.0 (3.0, 4.0) [152] 0.92
Note: Data reported as mean ± SD [n] for continuous variables and proportion (%) for categorical variables, time to 
delivery (hours) is reported as median (25th, 75th percentile) [n].  P-values adjusted for recruitment site (except for 
chorioamnionitis, meconium, shoulder dystocia, postpartum hemorrhage, and base deficit).  








Cesarean delivery 18/156 (11.5%) 23/153 (15.0%) 1.3 (0.7, 2.3) 0.87 
Cesarean delivery 
(adjusted for ketonuria)   1.4 (0.8, 2.4) 0.27
Time to delivery (hours) 12.1 (8.4, 18.0) [150] 12.8 (7.6, 18.3) [150] 0.69
Augmentation 88/156 (56.4%) 92/153 (60.1%) 1.1 (0.9, 1.3) 0.40
Any Operative Delivery 
(C/S, Forceps, Vacuum) 25/156 (16.0%) 31/153 (20.3%) 1.3 (0.8, 2.1) 0.31
Intrapartum fluids (ml)   
    Randomized fluid 2058 ± 1176 [109] 1472 ± 998 [115] <0.01
    Total fluids 2086 ± 1263 [110] 2043 ± 1378 [115] 0.89
Meconium 5/152 (3.3%) 4/150 (2.7%) 0.8 (0.2, 3.0) 0.75
Chorioamnionitis 6/152 (3.9%) 5/150 (3.3%) 0.8 (0.3, 2.7) 0.78
Postpartum hemorrhage 9/151 (6.0%) 2/149 (1.3%) 0.2 (0.0, 1.0) 0.05
Shoulder dystocia 5/152 (3.3%) 5/150 (3.3%) 1.0 (0.3, 3.4) 0.98
Umb artery gases    
    pH 7.24 ± 0.07 [48] 7.22 ± 0.08 [59] 0.67
    pH  ≤7.15 7/48 (14.6%) 12/59 (20.3%) 1.0 (0.5, 2.3) 0.96
    UA pCO2 54.8 ± 11.1 [49] 55.0 ± 11.4 [59] 0.55
    Base deficit >12 3/48 (6.3%) 6/58 (10.3%) 1.7 (0.4, 6.3) 0.46
Note: Data reported as mean ± SD [n] for normally distributed continuous variables, median (25th, 
75th percentile) [n] for non-normally distributed variables or ordinal variables, and proportion (%) for 
binary variables.  P-values adjusted for recruitment site.
Table 3: Neonatal outcomes compared between treatment       






Birth weight (g) 3428 ± 404 [156] 3408 ± 417 [153] 0.64 
Male sex 83/156 (53.2%) 83/153 (54.3%) 0.88
Apgar at 5min 9.0 (9.0, 9.0) [155] 9.0 (9.0, 9.0) [153] 0.06
Apgar at 5min, <7 0/155 (0.0%) 4/153 (2.6%) 0.06
Respiratory difficulty 4/153 (2.6%) 6/150 (4.0%) 0.52
Suspected sepsis 3/151 (2.0%) 2/144 (1.4%) 0.69
Neonatal hypoglycemia 7/50 (14.0%) 18/55 (32.7%) 0.05
Hyperbilirubinemia with 
phototherapy 3/154 (1.9%) 1/146 (0.7%) 0.36
NICU/special nursery 
admission 19/156 (12.2%) 17/153 (11.1%) 0.79
LATCH Scores 8.0 (7.0, 9.0) [90] 8.0 (7.0, 9.0) [87] 0.15
